TP53 and neoplasm: Notably, p53-null (p53−/−) mice, with any type of spontaneous tumor, did not show significantly extended survival under the same ATO treatment, supporting the dependence of p53-R279W on the therapeutic efficacy of ATO (Figures 1H–1K and S1J lower panel).